Organon & Co. (OGN) NYSE
6.36
+0.03(+0.47%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
6.36
+0.03(+0.47%)
Currency In USD
| Market Cap | 1.86B |
| Enterprise Value | 10.09B |
| P/E Ratio | 8.83 |
| PEG Ratio | -0.14 |
| Price/Sales Ratio | 0.27 |
| Price/Book Ratio | 2.2 |
| Enterprise/Revenue | 1.59 |
| Enterprise/EBITDA | 7.61 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.03 |
| Operating Margin | 0.2 |
| Return On Assets | 0.01 |
| Return On Equity | 0.26 |
| Revenue | 6.22B |
| Revenue/Share | 23.89 |
| Gross Profit | 3.36B |
| EBITDA | 1.28B |
| Net Income | 187M |
| Diluted EPS | 0.72 |
| Total Cash | 574M |
| Total Cash/Share | 2.21 |
| Total Debt | 8.8B |
| Total Debt/Equity | 11.7 |
| Current Ratio | 1.82 |
| Book Value Per Share | 2.89 |
| 52-Week Change | -58.52 |
| 52-Week High | 15.88 |
| 52-Week Low | 6.18 |
| Moving Average 50 Days | 7.88 |
| Moving Average 200 Days | 8.73 |
| Average Volume | 5.14M |
| Shares Outstanding | 260.32M |
| % Held by Institutions | 76.11 |
| Trailing Annual Dividend Rate | 0.08 |
| Trailing Annual Dividend Yield | 1.26 |
| Payout Ratio | 0.47 |
| Last Split Factor | N/A |
| Last Split Date | N/A |